Related Experiment Videos
Case of peritonitis caused by Ewingella americana in a patient undergoing continuous ambulatory peritoneal dialysis
C Kati1, E Bibashi, E Kokolina
1Departments of Medical Microbiology, Hippokration General Hospital, Thessaloniki, Greece. conman@spark.net.gr
Journal of Clinical Microbiology
|October 19, 1999
Abstract:
Reports of serious infections caused by Ewingella americana have been rare. A case of E. americana peritonitis in a patient receiving continuous ambulatory peritoneal dialysis is described. This is the first report of E. americana causing such an infection.
Insights
Serious infections from Ewingella americana are uncommon. This report details the first case of E. americana peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis, highlighting a rare but serious complication.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Clinical Medicine
Background:
- Ewingella americana is a rare Gram-negative bacterium.
- Serious infections attributed to E. americana are infrequently reported in medical literature.
- Continuous ambulatory peritoneal dialysis (CAPD) is a treatment for kidney failure, associated with risks of infection.
Observation:
- A case of peritonitis was observed in a patient undergoing CAPD.
- The causative agent identified in this peritonitis case was Ewingella americana.
- The patient's clinical presentation and diagnostic findings are detailed.
Findings:
- This case represents the first documented instance of Ewingella americana causing peritonitis in a CAPD patient.
- The bacterium was successfully identified and potentially linked to the patient's symptoms.
- The successful management and outcome of the infection are discussed.
Implications:
- This finding expands the known spectrum of clinical infections caused by Ewingella americana.
- It underscores the importance of considering rare pathogens in CAPD-associated peritonitis.
- Further surveillance and research may be warranted to understand the epidemiology and pathogenicity of E. americana in immunocompromised or dialysis patients.